ClinicalTrials.Veeva

Menu

Myocardial Contrast Echocardiography in Congenital Heart Disease

I

Insel Gruppe AG, University Hospital Bern

Status

Completed

Conditions

D-Transposition of Great Arteries
Tetralogy of Fallot

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Patients with congenital heart disease in whom the right ventricle is exposed to pressure or volume overload show progressive systolic dysfunction of the right ventricle, the fact of which conveys substantial morbidity and mortality. The aim of this study is to investigate the myocardial perfusion in these patients by myocardial contrast echocardiography (MCE) in order to determine whether disturbed blood flow plays a role in the development of right ventricular systolic dysfunction.

Enrollment

45 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • D-TGA or Fallot-Tetralogy or Healthy person
  • written informed consent
  • Age >= 18 years

Exclusion criteria

  • Anaemia
  • Pregnancy and breast feeding
  • Diabetes mellitus
  • Contraindications to stress testing (ergometry or adenosine)
  • Known adverse reaction or hypersensitivity against V08DA (SonoVue) or its components or against adenosine

Trial design

45 participants in 3 patient groups

TGA group
Description:
The TGA group consists of 15 patients treated withMustard or Senning procedures for surgical repaired of D-TGA atrial switch operation.
TOF group
Description:
The TOF group consists of 15 patients with surgically corrected TOF.
Control group
Description:
The control group C consists of 15 control subjects (AH) with normal Doppler Echocardiographic echocardiographic examinations.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems